{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:24:00Z","timestamp":1793773440595,"version":"4.6.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72800-2","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:49:43Z","timestamp":1779086983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-2511","authenticated-orcid":false,"given":"Umar K.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-6418","authenticated-orcid":false,"given":"Ayush","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivansh","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9966-1369","authenticated-orcid":false,"given":"Anjan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8049-1488","authenticated-orcid":false,"given":"Fabeha","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9224-2988","authenticated-orcid":false,"given":"Dilpreet K.","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afiya","family":"Dalwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Shendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Carskadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-2466","authenticated-orcid":false,"given":"Anjali","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avanish","family":"Saklani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-7550","authenticated-orcid":false,"given":"Sorab N.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0633-9772","authenticated-orcid":false,"given":"Nallasivam","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-9773","authenticated-orcid":false,"given":"Bushra","family":"Ateeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"72800_CR1","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","volume":"360","author":"E Van Cutsem","year":"2009","unstructured":"Van Cutsem, E. et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360, 1408\u20131417 (2009).","journal-title":"N. Engl. J. Med."},{"key":"72800_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/annonc\/mdu141","volume":"25","author":"JY Douillard","year":"2014","unstructured":"Douillard, J. Y. et al. Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer. Ann. Oncol. 25, 1346\u20131355 (2014).","journal-title":"Ann. Oncol."},{"key":"72800_CR3","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1200\/JCO.2018.78.3183","volume":"36","author":"S Qin","year":"2018","unstructured":"Qin, S. et al. Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patients with RAS wild-type metastatic colorectal cancer: the open-label, randomized, phase III TAILOR trial. J. Clin. Oncol. 36, 3031\u20133039 (2018).","journal-title":"J. Clin. Oncol."},{"key":"72800_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep18678","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci. Rep. 5, 18678 (2015).","journal-title":"Sci. Rep."},{"key":"72800_CR5","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.ejca.2015.05.017","volume":"51","author":"M Peeters","year":"2015","unstructured":"Peeters, M. et al. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials. Eur. J. Cancer 51, 1704\u20131713 (2015).","journal-title":"Eur. J. Cancer"},{"key":"72800_CR6","doi-asserted-by":"publisher","first-page":"C511","DOI":"10.1152\/ajpcell.00117.2015","volume":"309","author":"L Novellasdemunt","year":"2015","unstructured":"Novellasdemunt, L., Antas, P. & Li, V. S. Targeting Wnt signaling in colorectal cancer. A review in the theme: cell signaling: proteins, pathways and mechanisms. Am. J. Physiol. Cell Physiol. 309, C511\u2013C521 (2015).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"72800_CR7","doi-asserted-by":"publisher","unstructured":"Chen Y., Chen M., Deng K. Blocking the Wnt\/beta\u2011catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review). Int. J. Oncol.62, https:\/\/doi.org\/10.3892\/ijo.2022.5472 (2023).","DOI":"10.3892\/ijo.2022.5472"},{"key":"72800_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/jnci\/djp084","volume":"101","author":"K Garber","year":"2009","unstructured":"Garber, K. Drugging the Wnt pathway: problems and progress. J. Natl. Cancer Inst. 101, 548\u2013550 (2009).","journal-title":"J. Natl. Cancer Inst."},{"key":"72800_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan, T., Rindtorff, N. & Boutros, M. Wnt signaling in cancer. Oncogene 36, 1461\u20131473 (2017).","journal-title":"Oncogene"},{"key":"72800_CR10","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy, S. et al. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. Cancer Sci. 111, 3142\u20133154 (2020).","journal-title":"Cancer Sci."},{"key":"72800_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu, F. et al. Wnt\/beta-catenin signaling in cancers and targeted therapies. Signal Transduct. Target. Ther. 6, 307 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"72800_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2015.07.013","volume":"162","author":"HW Park","year":"2015","unstructured":"Park, H. W. et al. Alternative Wnt Signaling Activates YAP\/TAZ. Cell 162, 780\u2013794 (2015).","journal-title":"Cell"},{"key":"72800_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09898-0","volume":"10","author":"T Zhan","year":"2019","unstructured":"Zhan, T. et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat. Commun. 10, 2197 (2019).","journal-title":"Nat. Commun."},{"key":"72800_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104518","volume":"25","author":"S Narayan","year":"2022","unstructured":"Narayan, S. et al. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience 25, 104518 (2022).","journal-title":"iScience"},{"key":"72800_CR15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356 (2015).","journal-title":"Nat. Med."},{"key":"72800_CR16","doi-asserted-by":"publisher","first-page":"18698","DOI":"10.18632\/oncotarget.24617","volume":"9","author":"A Okita","year":"2018","unstructured":"Okita, A. et al. Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer. Oncotarget 9, 18698\u201318711 (2018).","journal-title":"Oncotarget"},{"key":"72800_CR17","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/annonc\/mdz387","volume":"30","author":"S Stintzing","year":"2019","unstructured":"Stintzing, S. et al. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial. Ann. Oncol. 30, 1796\u20131803 (2019).","journal-title":"Ann. Oncol."},{"key":"72800_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02677-z","volume":"23","author":"AM Khaliq","year":"2022","unstructured":"Khaliq, A. M. et al. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 23, 113 (2022).","journal-title":"Genome Biol."},{"key":"72800_CR19","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1126\/science.286.5448.2284","volume":"286","author":"JW Shay","year":"1999","unstructured":"Shay, J. W. & Wright, W. E. Mutant dyskerin ends relationship with telomerase. Science 286, 2284\u20132285 (1999).","journal-title":"Science"},{"key":"72800_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/990141","volume":"402","author":"JR Mitchell","year":"1999","unstructured":"Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551\u2013555 (1999).","journal-title":"Nature"},{"key":"72800_CR21","doi-asserted-by":"publisher","first-page":"e43147","DOI":"10.1371\/journal.pone.0043147","volume":"7","author":"B Liu","year":"2012","unstructured":"Liu, B., Zhang, J., Huang, C. & Liu, H. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PLoS ONE 7, e43147 (2012).","journal-title":"PLoS ONE"},{"key":"72800_CR22","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41416-020-01045-7","volume":"123","author":"KA Elsharawy","year":"2020","unstructured":"Elsharawy, K. A. et al. The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer. Br. J. Cancer 123, 1543\u20131552 (2020).","journal-title":"Br. J. Cancer"},{"key":"72800_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/mc.20715","volume":"50","author":"F Alawi","year":"2011","unstructured":"Alawi, F. & Lin, P. Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing. Mol. Carcinog. 50, 334\u2013345 (2011).","journal-title":"Mol. Carcinog."},{"key":"72800_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004344","volume":"8","author":"G Kan","year":"2021","unstructured":"Kan, G. et al. Dual Inhibition of DKC1 and MEK1\/2 Synergistically Restrains the Growth of Colorectal Cancer Cells. Adv. Sci. 8, 2004344 (2021).","journal-title":"Adv. Sci."},{"key":"72800_CR25","doi-asserted-by":"publisher","unstructured":"Bian, X. et al. Lipid metabolism and cancer. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20201606 (2021).","DOI":"10.1084\/jem.20201606"},{"key":"72800_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-023-02049-z","volume":"19","author":"ST Krishnan","year":"2023","unstructured":"Krishnan, S. T. et al. Staging of colorectal cancer using lipid biomarkers and machine learning. Metabolomics 19, 84 (2023).","journal-title":"Metabolomics"},{"key":"72800_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","volume":"688","author":"CR Gault","year":"2010","unstructured":"Gault, C. R., Obeid, L. M. & Hannun, Y. A. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688, 1\u201323 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"72800_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2011.11.001","volume":"51","author":"S Grosch","year":"2012","unstructured":"Grosch, S., Schiffmann, S. & Geisslinger, G. Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50\u201362 (2012).","journal-title":"Prog. Lipid Res."},{"key":"72800_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","volume":"18","author":"B Ogretmen","year":"2018","unstructured":"Ogretmen, B. Sphingolipid metabolism in cancer signalling and therapy. Nat. Rev. Cancer 18, 33\u201350 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"72800_CR30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1053\/j.gastro.2021.05.009","volume":"161","author":"J Ecker","year":"2021","unstructured":"Ecker, J. et al. The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature. Gastroenterology 161, 910\u2013923 (2021).","journal-title":"Gastroenterology"},{"key":"72800_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166906","volume":"1870","author":"K El Hindi","year":"2024","unstructured":"El Hindi, K. et al. Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 166906 (2024).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"72800_CR32","first-page":"3489","volume":"40","author":"SW Jang","year":"2018","unstructured":"Jang, S. W. et al. Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer. Oncol. Rep. 40, 3489\u20133500 (2018).","journal-title":"Oncol. Rep."},{"key":"72800_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrm4080","volume":"16","author":"AE Saliba","year":"2015","unstructured":"Saliba, A. E., Vonkova, I. & Gavin, A. C. The systematic analysis of protein-lipid interactions comes of age. Nat. Rev. Mol. Cell Biol. 16, 753\u2013761 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72800_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature07179","volume":"455","author":"R Firestein","year":"2008","unstructured":"Firestein, R. et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455, 547\u2013551 (2008).","journal-title":"Nature"},{"key":"72800_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg1805","volume":"9","author":"C Pederiva","year":"2023","unstructured":"Pederiva, C. et al. Control of protein synthesis through mRNA pseudouridylation by dyskerin. Sci. Adv. 9, eadg1805 (2023).","journal-title":"Sci. Adv."},{"key":"72800_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nrc.2016.55","volume":"16","author":"GM Arndt","year":"2016","unstructured":"Arndt, G. M. & MacKenzie, K. L. New prospects for targeting telomerase beyond the telomere. Nat. Rev. Cancer 16, 508\u2013524 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"72800_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1126\/science.2683079","volume":"246","author":"LH Hartwell","year":"1989","unstructured":"Hartwell, L. H. & Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629\u2013634 (1989).","journal-title":"Science"},{"key":"72800_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69083-y","volume":"10","author":"SA Buechler","year":"2020","unstructured":"Buechler, S. A. et al. ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing. Sci. Rep. 10, 12123 (2020).","journal-title":"Sci. Rep."},{"key":"72800_CR39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"HO Lee","year":"2020","unstructured":"Lee, H. O. et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet. 52, 594\u2013603 (2020).","journal-title":"Nat. Genet."},{"key":"72800_CR40","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm.3175","volume":"19","author":"A Sadanandam","year":"2013","unstructured":"Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619\u2013625 (2013).","journal-title":"Nat. Med."},{"key":"72800_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1158\/0008-5472.CAN-17-1357","volume":"78","author":"W Hankey","year":"2018","unstructured":"Hankey, W. et al. Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients. Cancer Res. 78, 617\u2013630 (2018).","journal-title":"Cancer Res."},{"key":"72800_CR42","doi-asserted-by":"publisher","first-page":"G455","DOI":"10.1152\/ajpgi.90381.2008","volume":"296","author":"RH Whitehead","year":"2009","unstructured":"Whitehead, R. H. & Robinson, P. S. Establishment of conditionally immortalized epithelial cell lines from the intestinal tissue of adult normal and transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G455\u2013G460 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"72800_CR43","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165\u2013D173 (2022).","journal-title":"Nucleic Acids Res."},{"key":"72800_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12944-019-0977-8","volume":"18","author":"A Pakiet","year":"2019","unstructured":"Pakiet, A., Kobiela, J., Stepnowski, P., Sledzinski, T. & Mika, A. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis. 18, 29 (2019).","journal-title":"Lipids Health Dis."},{"key":"72800_CR45","doi-asserted-by":"crossref","unstructured":"Fong Y. W., Ho J. J., Inouye C., Tjian R. The dyskerin ribonucleoprotein complex as an OCT4\/SOX2 coactivator in embryonic stem cells. Elife3, (2014).","DOI":"10.7554\/eLife.03573"},{"key":"72800_CR46","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1096\/fj.201600394R","volume":"30","author":"WC Huang","year":"2016","unstructured":"Huang, W. C. et al. Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J. 30, 2945\u20132958 (2016).","journal-title":"FASEB J."},{"key":"72800_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/BJ20111626","volume":"441","author":"TD Mullen","year":"2012","unstructured":"Mullen, T. D., Hannun, Y. A. & Obeid, L. M. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441, 789\u2013802 (2012).","journal-title":"Biochem. J."},{"key":"72800_CR48","doi-asserted-by":"publisher","first-page":"11369","DOI":"10.1074\/jbc.272.17.11369","volume":"272","author":"C Garcia-Ruiz","year":"1997","unstructured":"Garcia-Ruiz, C., Colell, A., Mari, M., Morales, A. & Fernandez-Checa, J. C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role mitochondrial glutathione. J. Biol. Chem. 272, 11369\u201311377 (1997).","journal-title":"J. Biol. Chem."},{"key":"72800_CR49","doi-asserted-by":"crossref","unstructured":"Jukes, Z. et al. Lipid profiling of mouse intestinal organoids for studying APC mutations. Biosci. Rep.41, BSR20202915 (2021).","DOI":"10.1042\/BSR20202915"},{"key":"72800_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159\u2013170 (1996).","journal-title":"Cell"},{"key":"72800_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.plipres.2010.10.003","volume":"50","author":"GA Patwardhan","year":"2011","unstructured":"Patwardhan, G. A. & Liu, Y. Y. Sphingolipids and expression regulation of genes in cancer. Prog. Lipid Res. 50, 104\u2013114 (2011).","journal-title":"Prog. Lipid Res."},{"key":"72800_CR52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1096\/fba.2020-00044","volume":"2","author":"KR Roy","year":"2020","unstructured":"Roy, K. R. et al. Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via beta-catenin-activated RNA methylation. FASEB Bioadv. 2, 653\u2013667 (2020).","journal-title":"FASEB Bioadv."},{"key":"72800_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9390878","volume":"2020","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. Role of Wnt\/beta-Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer. Biomed. Res. Int. 2020, 9390878 (2020).","journal-title":"Biomed. Res. Int."},{"key":"72800_CR54","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.molcel.2019.09.008","volume":"76","author":"R Riscal","year":"2019","unstructured":"Riscal, R., Skuli, N. & Simon, M. C. Even Cancer Cells Watch Their Cholesterol!. Mol. Cell 76, 220\u2013231 (2019).","journal-title":"Mol. Cell"},{"key":"72800_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J. Gastrointest. Surg. 15, 495\u2013519 (2023).","journal-title":"World J. Gastrointest. Surg."},{"key":"72800_CR56","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/annonc\/mdu039","volume":"25","author":"AJ Breugom","year":"2014","unstructured":"Breugom, A. J. et al. Quality assurance in the treatment of colorectal cancer: the EURECCA initiative. Ann. Oncol. 25, 1485\u20131492 (2014).","journal-title":"Ann. Oncol."},{"key":"72800_CR57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-0032-1325969","volume":"45","author":"European Colorectal Cancer Screening Guidelines Working Group","year":"2013","unstructured":"European Colorectal Cancer Screening Guidelines Working Group et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 45, 51\u201359 (2013).","journal-title":"Endoscopy"},{"key":"72800_CR58","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"72800_CR59","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1101\/gad.1476206","volume":"20","author":"JM Wong","year":"2006","unstructured":"Wong, J. M. & Collins, K. Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita. Genes Dev. 20, 2848\u20132858 (2006).","journal-title":"Genes Dev."},{"key":"72800_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02827-0","volume":"19","author":"G Kan","year":"2021","unstructured":"Kan, G. et al. Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma. J. Transl. Med. 19, 161 (2021).","journal-title":"J. Transl. Med."},{"key":"72800_CR61","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","volume":"12","author":"SA Savage","year":"2010","unstructured":"Savage, S. A. & Bertuch, A. A. The genetics and clinical manifestations of telomere biology disorders. Genet. Med. 12, 753\u2013764 (2010).","journal-title":"Genet. Med."},{"key":"72800_CR62","first-page":"43","volume":"730","author":"ND Nelson","year":"2012","unstructured":"Nelson, N. D. & Bertuch, A. A. Dyskeratosis congenita as a disorder of telomere maintenance. Mutat. Res. 730, 43\u201351 (2012).","journal-title":"Mutat. Res."},{"key":"72800_CR63","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cancergen.2011.11.002","volume":"204","author":"PJ Mason","year":"2011","unstructured":"Mason, P. J. & Bessler, M. The genetics of dyskeratosis congenita. Cancer Genet. 204, 635\u2013645 (2011).","journal-title":"Cancer Genet."},{"key":"72800_CR64","first-page":"365","volume":"28","author":"M Penzo","year":"2013","unstructured":"Penzo, M. et al. DKC1 gene mutations in human sporadic cancer. Histol. Histopathol. 28, 365\u2013372 (2013).","journal-title":"Histol. Histopathol."},{"key":"72800_CR65","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/0008-5472.CAN-09-4024","volume":"70","author":"L Montanaro","year":"2010","unstructured":"Montanaro, L. et al. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res. 70, 4767\u20134777 (2010).","journal-title":"Cancer Res."},{"key":"72800_CR66","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/sj.bjc.6605299","volume":"101","author":"P Sieron","year":"2009","unstructured":"Sieron, P. et al. DKC1 overexpression associated with prostate cancer progression. Br. J. Cancer 101, 1410\u20131416 (2009).","journal-title":"Br. J. Cancer"},{"key":"72800_CR67","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41416-019-0695-z","volume":"122","author":"P Hou","year":"2020","unstructured":"Hou, P. et al. DKC1 enhances angiogenesis by promoting HIF-1alpha transcription and facilitates metastasis in colorectal cancer. Br. J. Cancer 122, 668\u2013679 (2020).","journal-title":"Br. J. Cancer"},{"key":"72800_CR68","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.2169\/internalmedicine.5153-24","volume":"64","author":"H Watanabe","year":"2025","unstructured":"Watanabe, H. et al. Dyskeratosis congenita complicated by pulmonary fibrosis and myelodysplastic syndrome with a germline mutation of the DKC1 gene and a somatic mutation of the U2AF1 gene in leukocytes. Intern. Med. 64, 3000\u20133006 (2025).","journal-title":"Intern. Med."},{"key":"72800_CR69","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1172\/JCI122383","volume":"128","author":"B Madan","year":"2018","unstructured":"Madan, B. et al. Temporal dynamics of Wnt-dependent transcriptome reveal an oncogenic Wnt\/MYC\/ribosome axis. J. Clin. Invest. 128, 5620\u20135633 (2018).","journal-title":"J. Clin. Invest."},{"key":"72800_CR70","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/path.2640","volume":"220","author":"G Poulogiannis","year":"2010","unstructured":"Poulogiannis, G. et al. Prognostic relevance of DNA copy number changes in colorectal cancer. J. Pathol. 220, 338\u2013347 (2010).","journal-title":"J. Pathol."},{"key":"72800_CR71","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrg2593","volume":"10","author":"PJ Hastings","year":"2009","unstructured":"Hastings, P. J., Lupski, J. R., Rosenberg, S. M. & Ira, G. Mechanisms of change in gene copy number. Nat. Rev. Genet. 10, 551\u2013564 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"72800_CR72","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"K Kitatani","year":"2008","unstructured":"Kitatani, K., Idkowiak-Baldys, J. & Hannun, Y. A. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20, 1010\u20131018 (2008).","journal-title":"Cell Signal"},{"key":"72800_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.670353","volume":"11","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. NUDT21 Promotes Tumor growth and metastasis through modulating SGPP2 in human gastric cancer. Front. Oncol. 11, 670353 (2021).","journal-title":"Front. Oncol."},{"key":"72800_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc2875","volume":"10","author":"NJ Pyne","year":"2010","unstructured":"Pyne, N. J. & Pyne, S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 10, 489\u2013503 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"72800_CR75","doi-asserted-by":"publisher","unstructured":"Afrin, F. et al. Natural products and small molecules targeting cellular ceramide metabolism to enhance apoptosis in cancer cells. Cancers15, https:\/\/doi.org\/10.3390\/cancers15184645 (2023).","DOI":"10.3390\/cancers15184645"},{"key":"72800_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05613-7","volume":"9","author":"N Turner","year":"2018","unstructured":"Turner, N. et al. A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism. Nat. Commun. 9, 3165 (2018).","journal-title":"Nat. Commun."},{"key":"72800_CR77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1194\/jlr.M009142","volume":"52","author":"TD Mullen","year":"2011","unstructured":"Mullen, T. D. et al. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism. J. Lipid Res. 52, 68\u201377 (2011).","journal-title":"J. Lipid Res."},{"key":"72800_CR78","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.biocel.2011.12.019","volume":"44","author":"D Hartmann","year":"2012","unstructured":"Hartmann, D. et al. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int. J. Biochem. Cell Biol. 44, 620\u2013628 (2012).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"72800_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI0216127","volume":"110","author":"R Kolesnick","year":"2002","unstructured":"Kolesnick, R. The therapeutic potential of modulating the ceramide\/sphingomyelin pathway. J. Clin. Invest. 110, 3\u20138 (2002).","journal-title":"J. Clin. Invest."},{"key":"72800_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2023.151337","volume":"102","author":"J Alizadeh","year":"2023","unstructured":"Alizadeh, J. et al. Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy. Eur. J. Cell Biol. 102, 151337 (2023).","journal-title":"Eur. J. Cell Biol."},{"key":"72800_CR81","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.cellsig.2010.04.006","volume":"22","author":"J Mesicek","year":"2010","unstructured":"Mesicek, J. et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 22, 1300\u20131307 (2010).","journal-title":"Cell Signal"},{"key":"72800_CR82","doi-asserted-by":"publisher","unstructured":"Guerrieri, A. N. et al. DKC1 Overexpression induces a more aggressive cellular behavior and increases intrinsic ribosomal activity in immortalized mammary gland cells. Cancers12, https:\/\/doi.org\/10.3390\/cancers12123512 (2020).","DOI":"10.3390\/cancers12123512"},{"key":"72800_CR83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/jnci\/93.5.347","volume":"93","author":"A Senchenkov","year":"2001","unstructured":"Senchenkov, A., Litvak, D. A. & Cabot, M. C. Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93, 347\u2013357 (2001).","journal-title":"J. Natl. Cancer Inst."},{"key":"72800_CR84","doi-asserted-by":"publisher","unstructured":"Kretzschmar, T. et al. Long-chain and very long-chain ceramides mediate doxorubicin-induced toxicity and fibrosis. Int. J. Mol. Sci.22, https:\/\/doi.org\/10.3390\/ijms222111852 (2021).","DOI":"10.3390\/ijms222111852"},{"key":"72800_CR85","doi-asserted-by":"publisher","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","volume":"271","author":"Y Lavie","year":"1996","unstructured":"Lavie, Y., Cao, H., Bursten, S. L., Giuliano, A. E. & Cabot, M. C. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271, 19530\u201319536 (1996).","journal-title":"J. Biol. Chem."},{"key":"72800_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-022-00342-w","volume":"17","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Biol. Direct 17, 29 (2022).","journal-title":"Biol. Direct"},{"key":"72800_CR87","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1038\/s41388-021-01882-7","volume":"40","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer. Oncogene 40, 6601\u20136613 (2021).","journal-title":"Oncogene"},{"key":"72800_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108794","volume":"27","author":"N Manzar","year":"2024","unstructured":"Manzar, N. et al. An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer. iScience 27, 108794 (2024).","journal-title":"iScience"},{"key":"72800_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/labinvest.2017.131","volume":"98","author":"P Bankhead","year":"2018","unstructured":"Bankhead, P. et al. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Lab Invest. 98, 15\u201326 (2018).","journal-title":"Lab Invest."},{"key":"72800_CR90","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/biostatistics\/kxp059","volume":"11","author":"MN McCall","year":"2010","unstructured":"McCall, M. N., Bolstad, B. M. & Irizarry, R. A. Frozen robust multiarray analysis (fRMA). Biostatistics 11, 242\u2013253 (2010).","journal-title":"Biostatistics"},{"key":"72800_CR91","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","volume":"25","author":"A Kauffmann","year":"2009","unstructured":"Kauffmann, A., Gentleman, R. & Huber, W. arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25, 415\u2013416 (2009).","journal-title":"Bioinformatics"},{"key":"72800_CR92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"72800_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.23","volume":"4","author":"R Tiwari","year":"2015","unstructured":"Tiwari, R. et al. SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis 4, e162 (2015).","journal-title":"Oncogenesis"},{"key":"72800_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4705","volume":"35","author":"S Nigam","year":"2022","unstructured":"Nigam, S., Ranjan, R., Sinha, N. & Ateeq, B. Nuclear magnetic resonance spectroscopy reveals dysregulation of monounsaturated fatty acid metabolism upon SPINK1 attenuation in colorectal cancer. NMR Biomed. 35, e4705 (2022).","journal-title":"NMR Biomed."},{"key":"72800_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"72800_CR96","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72800_CR97","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/1078-0432.CCR-18-3230","volume":"25","author":"V Bhatia","year":"2019","unstructured":"Bhatia, V. et al. Epigenetic Silencing of miRNA-338-5p and miRNA-421 Drives SPINK1-Positive Prostate Cancer. Clin. Cancer Res. 25, 2755\u20132768 (2019).","journal-title":"Clin. Cancer Res."},{"key":"72800_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14184-0","volume":"11","author":"R Tiwari","year":"2020","unstructured":"Tiwari, R. et al. Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer. Nat. Commun. 11, 384 (2020).","journal-title":"Nat. Commun."},{"key":"72800_CR99","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ijc.33711","volume":"149","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N. et al. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Int. J. Cancer 149, 1495\u20131511 (2021).","journal-title":"Int. J. Cancer"},{"key":"72800_CR100","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/2153-3539.98813","volume":"3","author":"JS Almeida","year":"2012","unstructured":"Almeida, J. S. et al. ImageJS: Personalized, participated, pervasive, and reproducible image bioinformatics in the web browser. J. Pathol. Inf. 3, 25 (2012).","journal-title":"J. Pathol. Inf."},{"key":"72800_CR101","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"72800_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25623-2","volume":"12","author":"S Goel","year":"2021","unstructured":"Goel, S. et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat. Commun. 12, 5325 (2021).","journal-title":"Nat. Commun."},{"key":"72800_CR103","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 37, W652\u2013W660 (2009).","journal-title":"Nucleic Acids Res."},{"key":"72800_CR104","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen, K. P. et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat. Cancer 3, 232\u2013250 (2022).","journal-title":"Nat. Cancer"},{"key":"72800_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou, T. C. & Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzym. Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzym. Regul."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72800-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:02:13Z","timestamp":1779091333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72800"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72800-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent for the diagnosis of colorectal cancer has been granted by the Indian Patent Office (Patent No. 573132; Date: 31\n                      st\n                      October 2025), where B.A., U.K.K., A.G., and S.N. have been named as inventors. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4406"}}